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Abstract
Background: Life expectancy of older drug users has increased, primarily thanks to opioid agonist treatment
(OAT). Nursing homes are often not adapted to accommodate patients with substance use disorders. Although care
and adherence to polypharmacy in older opioid users need considerable resources e.g., daily visits to an outpatient
clinic, outpatient treatment and surveillance are provided as long as possible. We developed a novel medication
supply model with an electronic dispenser of pre-packed medications located at patient home, after allowing for law
requirements concerning the dispensing of opioids, and present preliminary results from three illustrative outpatients.
Methods: The community pharmacy provided unit-of-dose pouches with all solid oral medications directly to
patient home. Opioids for substitution were obtained at the addiction clinic in at least weekly intervals, otherwise in
the pouches. The pouches were loaded into a lockable, remote-controlled medication management aid that was
programmed according to the patient’s medication schedule. The dispenser reminds patients with acoustic alerts to
take their medication and records dates and times of medication retrievals. It automatically sends an alert if a patient
misses to retrieve a dose.
Results: Our three outpatients used the electronic dispenser during 659, 118 and 61 days, with a total of 5, 9,
and 18 pills to take daily at 1, 3 and 5 intake times, respectively. The majority of the doses were taken on the preset
time (94%, 68.2% and 73.7%) or deliberately in advance (pocket dose). Clinical benefits were initiation and
maintenance of a therapy for dementia over 18 months and suppression of HIV viral load over 1.8 years (patient 1),
prevention of further dose escalation of pain medication (patient 2) and release of prompts to initiate the existential
task of cooking (patient 3).
Conclusion: Our novel supply model allows adequate implementation and persistence of complex treatments
with outpatients. Clinical outcomes improved, patients and caregivers were satisfied, and resources were saved.
Keywords: Electronic medication dispenser; Electronic adherence
monitoring; Medication management aid; Polypharmacy; Opioid
agonist treatment; Interprofessional collaboration; Solution; Unit-of-
dose pouches
Introduction
Adherence is defined as “the process by which patients take their
medications as prescribed, composed of initiation, implementation
and discontinuation” [1]. Persistence describes the time length
between the first and the last dose i.e., between initiation and
discontinuation. However, being persistent does not imply that the
actual dosing corresponds to the prescribed regimen. Modern
medicine has developed a multitude of evidence-based treatments for
many chronic diseases. As a result, the prescription of several
medications to treat one or more conditions in the same patient has
become increasingly common, especially in the elderly [2,3]. In the
United States and Europe, more than 50% of elderly patients use more
than 5 prescription medications [4,5]. With the demographic shift
toward older age and the concurrent increase in morbidity, the
prevalence of polypharmacy will likely increase in the future,
representing an additional factor contributing to non-adherence [6].
Along with the aging of the general population, the number of older
users of illicit substances (or older drug users) is also growing in
Europe [7] and in Switzerland [8]. Owing to harm reduction services
(such as needle and syringe programs), significant improvements in
availability, access and quality of treatment (such as highly active anti-
retroviral therapy (HAART) for HIV/AIDS) and opioid agonist
treatment (OAT), life expectancy has increased in older drug users.
Consequently, they may be affected on the one hand by progressive
conditions such as HIV or chronic hepatitis C virus (HCV) infection
that may take decades to cause significant illness or death, and on the
other hand by age-related comorbidities. Moreover, older drug users
are likely to suffer from neurocognitive deficits. This may result from
the accelerated aging process or from mental health effects of
polysubstance use, overdoses and infections [9]. Finally, older drug
users are often socially excluded or marginalised. Thus, support from
family or friends is mostly inexistent or unreliable. OAT is the main
evidence-based treatment for heroin dependence and is the treatment
of first choice in many international guidelines (WHO, NICE). It is
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efficacious, cost-effective and well tolerated [10]. Currently, traditional
OAT with liquid Methadone is increasingly being replaced by solid
formulations such as Buprenorphine or sustained-release Morphine
[11]. Besides OAT, many older drug users take several long-term
medications. These findings have multiple implications, in particular
with respect to the often complex multiple medication
(polypharmacy). Thus, older patients on OAT may be particular prone
to errors in medication intake. Correct implementation of treatment is
crucial for opioid dependent patients, not only to guarantee optimal
treatment of the underlying illness, but also to minimize dependence
and withdrawal symptoms. In addition, the treatment of chronic viral
conditions such as HIV or HCV is expensive and require adherence
rates of more than 95% to be effective [12], forcing health care
professionals to develop strategies that guarantee medication intake,
e.g. with outreach and low-threshold specialized outpatient centres and
direct observed therapy (DOT). As a consequence, treatment of older
drug users evolves into intensive and resource consuming care. Thus,
new solutions for the achievement of sustainable and affordable care
are needed.
Finally, with approximatively 2 million people being addicted to
prescription opioids for chronic pain in the United States, the
magnitude of opioid use and misuse in the US has been recently
described as epidemic [13]. Because substance use disorders such as
opioid dependence often coincide with multiple risk factors for
medication non-adherence (such as unemployment or low social
support), health care professionals are called to change their practice.
In this spirit, the Surgeon General of the United States advocated for
treatment programs including monitoring of medicine use [13].
To conclude, alternative supply models are needed to assist patients
with their medication management and to optimize adherence,
including chronic opioid users for any reason. Adherence management
is defined as “the process of monitoring and supporting patients’
adherence to medications by health care systems, providers, patients,
and their social networks” [1]. Thus, management of adherence begins
with the monitoring of said behaviour, and flows into a targeted
intervention to improve adherence, if needed. We developed a novel
medication supply model with interprofessional collaboration between
an outpatient addiction clinic and a community pharmacy in Basel,
Switzerland, with the aim of guaranteeing adherence to polypharmacy
by using an electronic dispenser of pre-packed medications located at
patient home. We tested the feasibility of our novel medication supply
model with three illustrative outpatients and present preliminary
results.
Methods
Remote-controlled electronic monitoring with pre-packed
unit-of-dose pouches
Solid oral prescription medications are repacked into unit-of-dose
pouches (Automatic Tablet Dispensing and Packaging System, Desk
Type JV-30DE, HD-Medi, Germany). Each pouch is imprinted with
the patient’s data (name, date of birth) and medication data (number,
name, date and time for intake, color, shape of the medication; Figure
1).
Figure 1: Unit-of-dose pouches with prepacked oral solid medication as roll (A), two pouches from front-side (B) and back-side (C). Note:
patient’s name and date of birth were concealed for privacy reasons.
Rolls of pouches for 1-3 weeks are placed in a remote controlled,
electronic medication management aid reminding the patients with
acoustic alerts to take their medication (Medido®, Innospense BV,
Netherlands; Figure 2).
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Figure 2: Remote-controlled, electronic medication management
aid, medido®, used in this study to dispense the unit-of-dose
pouches (Height × Width × Length: 140 mm × 140 mm × 225 mm;
Weight: 1.48 g).
A web-based application allows to set the time of dispense
individually according to participants’ preferences. Pushing the OK-
button stops the alarm and delivers the pouches with the pre-packaged
medication. A sensor in the dispenser registers a barcode printed on
the top of each pouch and cuts the pouches accordingly. Date and time
of delivery are simultaneously transmitted to a secure server with
GPRS-technology. Doses can be delivered ahead of schedule (so-called
pocket-doses) by pushing the OK-button for 5 seconds. This feature
enables patient mobility i.e., to be outside of home during intake times.
The dispenser is installed at the patient’ home and patient is orally
instructed about its proper use. A written manual is given including a
telephone hotline number in case of technical problems with the
dispenser. A former qualitative analysis of the dispenser suggested that
patients with time-sensitive medication regimens could benefit best
[14]. Further, a similar type of electronic dispenser has been
considered safe to provide OAT [15].
Novel supply model
Core element of the novel supply model is the respect of existing law
requirements concerning opioid dispensing, and the supply of the
entire co-medication at the patients’ home with an electronic guardian.
Figure 3: Novel medication supply model where the community pharmacy provides unit-of-dose pouches (medication roll Mo-Su) with the
solid oral medications directly to patient home, including opioid (path A). Depending on the regulations in force, patients with opioid agonist
therapy must obtain the opioid (S) at the outpatient addiction clinic in regular intervals, in Switzerland at least once weekly (dotted line). For
these patients, the pharmacy delivers the opioid agonist directly to the clinic (path B). At the patient home, the pouches are loaded into a
lockable, remote-controlled dispenser that can be programmed according to a patient’s medication schedule. The dispenser records dates and
times of medication retrievals and wirelessly transmits them to a server (blue waves).
Patients obtain the opioid either for pain treatment together with all
medications through official pharmacy services (Figure 3, path A) or
for substitution from the addiction clinic in regular intervals, at least
once weekly according to Swiss law (Figure 3, path B). After having
performed a medication review, the community pharmacy determines
an appropriate treatment schedule with the patient, and provides unit-
of-dose pouches with all solid oral medications directly to patient
home, either with (path A) or without (path B) opioid.
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Monitoring-induced actions
If a patient misses to retrieve a dose from the dispenser after a
predefined time of intake (in our study the grace period was preset at
75 minutes) or in case of malfunctioning, the dispenser automatically
sends an alert. In our study, we selected alerts to be sent via short
message service (SMS) to the hotline number that was operated by a
pharmacist of the research group (SA or IA) during weekdays and by
the Emergency Pharmacy during weekends and public holidays. The
person in charge of the hotline then contacts the patient by phone call,
inquires the situation and acts accordingly.
The password-protected, web-based application can be consulted at
any time and indicates with a color code how the pouches have been
dispensed (Figure 4). In case of a technical problem, the pharmacist
can either resolve it by remote action or with a visit at the patient
home. In any case, he makes sure that medication has been taken.
Figure 4: Web-based application of medido® with colour coded retrievals of pouches during one week (January 17th to 23th, 2017) for a patient
with a twice daily intake of two pouches at 10 am (10:00) and one pouch at 6 pm (18:00). A dispense time before the predefined time is
indicated in orange (pocket-dose); a dispensing within a preset grace period (here 75 minutes) after the predefined time of intake is indicated
in green (regular dose); a dispensing after 75 minutes is blue (late dose); and a forgotten dispense is red (missed dose).
Patient selection
We recruited three patients from an outpatient addiction clinic
(Division of Substance Use Disorders, Psychiatric University Clinics of
Basel) with different reasons for opioid treatment. All have been
obtaining all medications including opioids from the outpatient clinic
for years. Because of unmet clinical goals (i.e., flares of HIV viral load
for patient 1; inadequate pain relief despite dose escalation for patient
2; malnutrition and hypovitaminosis for patient 3), conventional care
and adherence to medication were questioned. Repetitively missed
appointments at the clinic, mostly due to impaired mobility, impeded
daily medication dispensing or daily direct observed therapy. Thus, the
situation remained unsatisfactorily for the health care professionals.
Our patients received no or little support from family or friends.
During visits at the clinic, they admitted to have frequently missed
medication intakes during the past 4 weeks. They accepted the offer of
their caregivers to obtain medications with the novel supply model.
All three patients were unemployed, lived independently in social
housing either alone (patient 3) or with a friend (patient 1) or a grand-
child (patient 2) in Basel, a mid-size city in Switzerland. Patient 1 was
HIV-positive since 25 years consecutive to intravenous drug abuse and
joined a Methadone program that was switched in 2013 to 1,200 mg
long-acting Morphine daily (6 tablets) consecutive to a long QT-
syndrome.
Patient 2 had immobilizing chronic pain treated with long-acting
morphine (1,000 mg) and various co-analgesics. She was hospitalized
two weeks after entering the study, and entered stationary psychiatric
rehabilitation, where the dispenser was not in use. After her return
home, she resumed medication dispense from the electronic dispenser.
Patient 3 experienced malnutrition and hypovitaminosis after
partial gastric resection due to obesity. She had developed severe
lymphedema in her legs after an infection, which lead to sustained
impairment of her mobility. She lacked impetus and often slept in,
disturbing her daily routine.
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Results
All three patients understood that the electronic dispenser would
bring a benefit for their medication management. They accepted the
novel medication supply model and gave written consent. They were
aware of the electronic monitoring and the automatic alarms in case of
missed dispense. The dispensers were installed in the kitchen (patient 1
and 3), or in the living room (patient 2). Dispensing times were
scheduled in line with consistent habits of daily life i.e., 12pm for
patient 1 (first meal of the day), and according to meals and watching
TV for patient 2 and 3 (see Table 1). Every 3 weeks, medications were
repackaged according to the current treatment plan and the dispenser
was refilled during a pre-scheduled visit at the patient home. On this
occasion, patients were asked about their well-being, difficulties with
the use of the dispenser, and whether they had taken their medication
immediately after retrieval of the pouches from the dispenser. Patients
declared to be satisfied with the novel supply model, and the few
technical problems did not jeopardize medication intake. Errors
during the dispensing of the pouches occurred predominantly at the
end of a medication roll, and did not require any intervention.
Patient 1 Patient 2 Patient 3
Age at (study entry) 50 (July 2, 2013) 68 (Feb 25, 2015) 36 (July 17, 2015)
Main diagnoses
HIV, HCV, liver cirrhosis,
beginning Alzheimer’s disease
polyarthrosis, recurrent depressive disorder,
Basedow-Graves disease, hypertensive
heart failure malnutrition, hypovitaminosis
Number of medicines (number of
pills) 5 (5) 13 (18) 7 (9)
Number of intake times 1 5 3
Number of medications in pouches
@ preset dispense time : name and
strength of medication
5@12h00: ritonavir 100 mg +
darunavir 800 mg + tenofovir/
emtricitabine 245/200 mg +
pantoprazole 40 mg +
donepezil10 mg
2@6h00: morphine SR 400 mg + L-
thyroxine 0.1 mg
8@8h00: metamizole 500 mg + sertraline
100 mg + aspirin 100 mg + nebivolol 2.5 mg
+ torasemide 10 mg + calcium/vitamin D 500
mg/800 IE + folic acid 5 mg + iron
2@12h00: metamizole 500 mg + iron
3@18h00: atorvastatin 20 mg +
metamizole 500 mg + morphine SR 600 mg
3@22h00: metamizole 500 mg +
mirtazapine 30 mg + zolpidem 10 mg
5@10h00: multivitamins + calcium/vitamin
D 500 mg/800 IE + zinc + pregabalin 150
mg
2@12h00: calcium/vitamin D 500 mg/800
IE + pregabalin 150 mg
2@18h00: quetiapine 150 mg +
trimipramine 100 mg + diazepam 40 mg
Opioid dispense At clinic weekly (not monitored) In pouch At clinic weekly (not monitored)
Days of follow-up (study end) 659 (Apr 2, 2015) 61 (Apr 28, 2015) 118 (Nov 11, 2015)
Number of rolls replacement 31 7 13
Days with electronic monitoring 655 45 118
Regular dose (green) 615 (94.0%) 98 (73.7%) 281 (68.2%)
Pocket dose (orange) 1 (0.2%) 29 (21.8%) 121 (29.4%)
Late dispense (blue) 8 (1.2%) 2 (1.5%) 0
Missed doses (red) 4 (0.6%) 4 (3%) 10 (2.4%)
Table 1: Characteristics of the 3 illustrative patients with number of pills, number of pouches and preset time of intakes. Regular dose: the doses
were dispensed within 75 minute after the preset intake time; Pocket dose: the doses were dispensed before the preset intake time; Late dispense:
the doses were dispensed later than 75 minute after the preset intake time; Missed doses: the doses were dispensed remotely after a pharmacist
intervention. The colours correspond to the codes used in Figure 4.
For patient 1, the use of the electronic dispenser enabled to initiate a
therapy for dementia and to maintain it over 18 months, to obtain
constant suppression of viral load and rising of CD4 cells over 1.8 years
and to stay in his housing. According to his care givers, the novel
supply model delayed patient’s first admission to a nursing home by
approximately 1 year. For patient 2, the electronic dispenser assured
the timely and correct intake of her pain medication and prevented
further dose escalations. The remote monitoring made daily visits to
the clinic obsolete and allowed her to stay at her home, according to
her immobility. For patient 3, the dispenser added a clear structure to
her day and provided the necessary prompts to take her medications.
Subsequently, she used the medication alarms as reminders to initiate
other tasks e.g., preparing a meal. As a result, her vitamin levels
improved.
Dispensing the pouch before the predefined time (pocket dose)
occurred approximatively for 25% of the doses for two patients. This
corresponds to a phase of psychiatric rehabilitation program for
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patient 2 where she regularly retrieved pocket-doses in the morning
before entering the clinic. Patient 3 started the study with 4 pre-
scheduled times (10h00, 12h00, 18h00 and 20h00) and would spend
most of the time at home. After 2 months, the latest time of intake was
eliminated because the beeping in the evening was inconvenient,
especially when friends would come to her place. Thus, what was
recorded as pocket dose was in fact a deliberate dose.
Discussion
Existing nursing homes or home care services are scarce and
expensive, and often not adapted to accommodate patients with
substance use disorders such as older opioid users. Therefore,
outpatient treatment and surveillance are provided as long as possible.
However, considerable resources in infrastructure and staff are needed
to guarantee care and adherence to polypharmacy in an aging
population with opioid agonist treatment, such as daily visits to an
outpatient clinic. Thus, new supply models and innovative solutions
are needed that combine provision of care and optimization of
medication management compatible with opioid treatment. In this
regard, electronic dispensers of prepacked polypharmacy offer a
unique opportunity. They allow adequate implementation and
persistence of a complex treatment with patients staying at home, and
rely on a system of alerts in case of problems.
In our study, follow-up times differed from case to case for various
reasons, but not attrition. Patient 1 refused to quit the study after its
official completion (6 months) predominantly because of the sheltered
situation of a safe medication dispensing at home that was made
possible by the dispenser. Ethical considerations forced the
investigators to maintain the dispenser and the service in place until
the patient entered a nursing home. Patient 2 deceased after 14 weeks
(death unrelated to the study). Patient 3 finished the study after its
official duration and could maintain the gained structured living
habits. Thus, our intervention with remote technology has the potential
to improve adherence to polypharmacy and to engrave new behaviours
into daily habits. However, some patients may need the service forever.
Several major benefits are obtained with multiple medication
supplied in unit-of-dose pouches. For example, changes in treatment
are implemented without disturbances for the patient, especially when
the new medication can be added to a pre-existing pouch; up-titration
is feasible without errors, such as weekly dose increases of a
medication for dementia; initiation of preventive and irregular
treatment is guaranteed without errors, such as prophylaxis of
Pneumocystis carinii in HIV treatment with one tablet three time per
week (sulmamethoxazole/trimethoprime 800 mg/160 mg Monday,
Wednesday and Friday); and adaptation of the content of the pouches
is possible without modifying the intake habits. Larger trials with
similar devices suggest an improvement of adherence and clinical
outcomes for patients with such diverse conditions as kidney
transplantation [16] or schizophrenia [17]. However, study duration
was mostly short and implementation of dosing regimens was not a
main focus of interest. With our proposed supply model, clinical
outcomes improved, patients and caregivers were satisfied, and
resources were saved. Further, the number of on-site visits decreased,
leaving the remaining visits entirely for discussion about current
findings, and not about medication supply.
Mathematically, the novel supply model generated more costs than
standard care, predominantly due to the addition of a dispenser, a
hotline and pharmacists’ work. The dispenser we used is not routinely
available in Switzerland and the costs remain high at the moment.
However, on the long term, costs might be saved for several reasons.
First, the market price of the device after commercialisation might
decrease, and a hotline might be integrated as part of the service.
Second, pharmacists’ work would be saved when patients would collect
the rolls of medication at the clinic during a routine visit and refill the
dispenser by themselves. Further, the number of visits to the clinic may
decrease, in the extreme cases from several times daily (for direct
observed therapy) to once weekly (as required by law for OAT). Thus,
this increased independence might enable younger patients to pursue
paid employment. Finally, postponement of assisted living may save
large amounts of money to society.
Conclusion
Electronic medication management aids offer a sustainable solution
for integrated care with an interprofessional approach (hospital or
specialized clinic and community pharmacy) and can assure adequate
implementation of and persistence with complex oral treatment.
Electronic devices with prepacked unit-of-dose medications may
ensure correct dosing regimens for patients with polypharmacy
including opioid for any reasons. On the long term, the avoidance of
more expensive alternatives such as direct observed therapy or nursing
homes might offset the additional costs generated by our novel supply
model.
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